Shanrong Biotechnology (SRBT) Stock Statistics & Valuation Metrics
Total Valuation
Shanrong Biotechnology has a market cap or net worth of $102.55K. The enterprise value is -$1.60B.
- Market Cap
- $102.55K
- Enterprise Value
- -$1.60B
Share Statistics
Shanrong Biotechnology has 1,025,483,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,025,483,800
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Shanrong Biotechnology’s return on equity (ROE) is 1.03 and return on invested capital (ROIC) is -479.31%.
- Return on Equity (ROE)
- 1.03
- Return on Assets (ROA)
- -4.32
- Return on Invested Capital (ROIC)
- -479.31%
- Return on Capital Employed (ROCE)
- -4.79
- Revenue Per Employee
- 0
- Profits Per Employee
- -26.33K
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Shanrong Biotechnology is -0.00. Shanrong Biotechnology’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -1.30
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Shanrong Biotechnology had revenue of 0 and earned -78.98K in profits. Earnings per share was -0.16.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -78.99K
- Pretax Income
- -78.98K
- Net Income
- -78.98K
- EBITDA
- -78.99K
- Earnings Per Share (EPS)
- -0.16
Cash Flow
In the last 12 months, operating cash flow was -109.41K and capital expenditures 0, giving a free cash flow of -109.41K billion.
- Operating Cash Flow
- -109.41K
- Free Cash Flow
- -109.41K
- Free Cash Flow per Share
- -0.16
Dividends & Yields
Shanrong Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -77.13%
- Earnings Yield
- -48501.30%
Stock Price Statistics
- Beta
- 3.76
- 52-Week Price Change
- -72.73%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.06
- Relative Strength Index (RSI)
- 16.53
- Average Volume (3m)
- ―
Financial Position
Shanrong Biotechnology as a current ratio of 10.07, with Debt / Equity ratio of 0.00%
- Current Ratio
- 10.07
- Quick Ratio
- 10.07
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.23
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Shanrong Biotechnology has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Shanrong Biotechnology EV to EBITDA ratio is -4.17, with an EV/FCF ratio of -1.27.
- EV to Sales
- 0.00
- EV to EBITDA
- -4.17
- EV to Free Cash Flow
- -1.27
- EV to Operating Cash Flow
- -1.27
Balance Sheet
Shanrong Biotechnology has $1,804.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $1,804.00 billion.
- Cash & Marketable Securities
- $1,804.00
- Total Debt
- $0.00
- Net Cash
- $1,804.00
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Shanrong Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
